Vaccine makers start work on jabs versus Omicron

BioNTech, Moderna and Johnson & Johnson are working on vaccines that specifically target Omicron in case their existing shots are not effective against the new coronavirus variant, the companies said on Monday, November 29.

Maaaring larawan ng text

BioNTech SE said it had started work on a vaccine tailored to Omicron, along with partner Pfizer.

Moderna Inc said it could take months to begin shipping such a vaccine.

Johnson & Johnson is also evaluating the effectiveness of its COVID-19 vaccine against Omicron, while also pursuing a vaccine specific to the variant.

The variant’s emergence has triggered a strong global response as countries worry that it could spread fast even in vaccinated populations.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s